Immunic Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunic granted inducement equity awards covering an aggregate 196,350 shares to seven new employees between September 14 and September 28, 2026. The grants were made under the 2026 Inducement Equity Compensation Plan pursuant to Nasdaq Listing Rule 5635(c)(4), vesting 25% on the first anniversary of hire with the remainder vesting monthly over 36 months.
Key figures
- Shares Offered
- 196350
- Vesting
- 25% at first anniversary of hire, remainder monthly over 36 months
- Grant type
- inducement equity grants (options)
- Employees receiving grants
- 7
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.